Part F
— Chapter
PCT-EPO Guidelines
4.11 Computer programs
See ISPE Guidelines 4.23.
4.12 Physical values, units
See ISPE Guidelines 4.24 See also GWEPO F-ll„ Annex 2.
4.13 Registered trademarks
March 2022
Rule
Rules 1110-11.13
Rule 52
Rule g 1
Rule g 10) and
Section F-ll, 414 in the Guidelines for Examination in the SPO applies
mutatis mutandis
5. Drawings
5.1 Form and content of the drawings
See GUPCT-EPO A-V and ISPE Guidelines 4.28.
5.2 Photographs
The PCT Regulations are silent with regard to photographs. Nevertheless,
they are allowed where what is to be shown (for instance, crystalline
structures) cannot possibly be presented in a drawing. See
GWPCT-EPO 12,
PCT AG 1 5.159
and
PCT Receiving Office Guidelines, Chapter VI, paragraph 146 (GURO 146).
Section F-lll 5.3 in the Guidelines for Examination in the EPO applies
mutatis mutandis
6. Nucleotide and amino acid sequence listings
See ISPE- Guidelines 4.15 and Euro-PCT Guide, points 2.22.001-2.22.006_
For handling of non-compliant nucleotide and/or amino acid sequence
listings at the search stage and during the PCT Chapter II procedure, see
GWPCT-EPO and GWPCT-EPO c-VIII, 2.1, respectively.
6.1 Reference to sequences disclosed in a database
Section F-ll, & 1 in the Gui<elines for Examination in the EPO applies
mutatis mutandis
7. Expressions, etc., not to be used
7.1 Categories
There are four categories of expressions which should not be contained in
an intemational application, as specified in Rule 9.1. See
'SPE Guidelines 4_29
7.2 Expressions or drawings contrary to morality or public order
See ISPE Guidelines 4.29.
With regard to patentability
see GUPCT-EPO G-ll. 41.
Issues
with
such
matter,
